UPDATE: BMO Capital Downgrades Alnylam Pharmaceuticals (ALNY) to Market Perform
Tweet Send to a Friend
(Updated - January 25, 2021 12:37 AM EST)
BMO Capital analyst Do Kim downgraded Alnylam Pharmaceuticals (NASDAQ: ALNY) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
BMO Capital analyst Do Kim downgraded Alnylam Pharmaceuticals (NASDAQ: ALNY) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
